{
    "id": "63f02e1bf36125a426000016",
    "question": "Was AAVS3 developed for hemophilia A?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"AAVS3 (Adeno-Associated Virus Vector Serotype 3) is a viral vector used in gene therapy. To determine if it was developed for hemophilia A, we need to consider its primary application. AAVS3 is primarily used in gene therapy for the treatment of sickle cell disease and Leber congenital amaurosis (a form of inherited blindness), but not typically for hemophilia A. Hemophilia A is usually treated with factor VIII replacement therapy, not gene therapy using AAVS3. However, researchers have explored the use of AAVS3 for other conditions, including hemophilia A, but this is not its primary application. \", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 4.168732643127441
}